About: Clinical characteristics of Coronavirus Disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Clinical characteristics of Coronavirus Disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Clinical characteristics of Coronavirus Disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases
Creator	Liu, Jing Zhang, Heng Zhang, Hu Gong, Jing Liao, Yu-Sheng Xia, Xi
Source	Elsevier; Medline; PMC
abstract	Abstract Objective To explore the clinical characteristics of Coronavirus Disease (COVID-19) patients with gastrointestinal symptoms. Methods The clinical data of 164 COVID-19 patients with gastrointestinal symptoms were extracted and analysed retrospectively. Results In total, 505 COVID-19 patients were divided into two groups: those with gastrointestinal symptoms (G group) and those without gastrointestinal symptoms (NG group). Common gastrointestinal symptoms included inappetence, diarrhoea, nausea, abdominal pain, and vomiting. Significantly higher proportions of patients with fever, dizziness, myalgia, and fatigue were noted in group G than in group NG. Compared with patients without fever, there was a significant difference between G group and NG group in moderate fever or above, while there was no significant difference between the two groups in low fever. The laboratory results showed that patients in the G group had significantly higher C-reactive protein, lactate dehydrogenase, and α-hydroxybutyrate dehydrogenase levels than those in the NG group. Moreover, the proportion of patients with severe pneumonia was significantly higher in the G group than in the NG group. Conclusion In Wuhan, the proportion of COVID-19 patients who experience gastrointestinal symptoms is relatively high. Patients who experience gastrointestinal symptoms are more likely to suffer from severe pneumonia, which may help clinicians identify patients at high risk of COVID-19 and thus reduce the incidence of this condition.
has issue date	2020-05-08(xsd:dateTime)
bibo:doi	10.1016/j.dld.2020.04.034
bibo:pmid	32507692
has license	els-covid
sha1sum (hex)	e3fb47b53690d912c46406193452baa372e48d86
schema:url	https://doi.org/10.1016/j.dld.2020.04.034
resource representing a document's title	Clinical characteristics of Coronavirus Disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases
has PubMed Central identifier	PMC7205655
has PubMed identifier	32507692
schema:publication	Dig Liver Dis
resource representing a document's body	covid:e3fb47b53690d912c46406193452baa372e48d86#body_text
is schema:about of	named entity 'Disease' named entity 'Coronavirus' named entity 'COVID-19' named entity 'CLINICAL CHARACTERISTICS' named entity 'CORONAVIRUS DISEASE' covid:arg/e3fb47b53690d912c46406193452baa372e48d86 named entity 'patients' named entity 'patients' named entity 'gastrointestinal symptoms' named entity 'gastrointestinal symptoms' named entity 'Clinical characteristics' named entity 'Huazhong University of Science and Technology' named entity 'significant difference' named entity 'chronic liver disease' named entity 'gastrointestinal symptoms' named entity 'clinical diagnostic' named entity 'gastrointestinal symptoms' named entity 'viral infections' named entity 'clinical characteristics' named entity 'infection' named entity 'SARS-CoV-2' named entity 'Huazhong University of Science and Technology' named entity 'RNA' named entity 'gastrointestinal symptoms' named entity 'creatinine' named entity 'severe pneumonia' named entity 'MERS' named entity 'COVID' named entity 'hypertension' named entity 'alveolar epithelial cells' named entity 'ACE2' named entity 'drug-induced' named entity 'inflammation' named entity 'activated lymphocytes' named entity 'Coronavirus disease' named entity 'oesophagus' named entity 'clinical characteristics' named entity 'SARS-CoV-2' named entity 'antibiotic' named entity 'cohort study' named entity 'severe pneumonia' named entity 'faeces' named entity 'gastrointestinal symptoms' named entity 'SARS-CoV-2' named entity 'coronavirus' named entity 'systemic inflammatory response syndrome' named entity 'COVID' named entity 'China' named entity 'renal function' named entity 'China' named entity 'COVID' named entity 'tropism' named entity 'acute respiratory infection' named entity 'chronic lung disease' named entity 'SARS-CoV-2' named entity 'COVID' named entity 'Comorbidities' named entity 'gastrointestinal symptoms' named entity 'MERS' named entity 'severe pneumonia' named entity 'diarrhoea' named entity 'CT scans' named entity 'white blood cells' named entity 'gastrointestinal symptoms' named entity 'gastrointestinal symptoms' named entity 'COVID-19' named entity 'autopsy' named entity 'COVID' named entity 'gastrointestinal symptoms' named entity 'nucleic acid test' named entity 'CRP' named entity 'diarrhoea' named entity 'SPSS' named entity 'nucleic acid' named entity 'Wuhan' named entity 'SARS-CoV-2'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software